GAROFALO, MARIANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.235
AS - Asia 3.068
EU - Europa 1.709
AF - Africa 584
SA - Sud America 474
Continente sconosciuto - Info sul continente non disponibili 135
OC - Oceania 56
Totale 11.261
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.894
SG - Singapore 936
IT - Italia 605
CN - Cina 512
VN - Vietnam 427
BR - Brasile 280
HK - Hong Kong 276
BD - Bangladesh 196
FR - Francia 108
DE - Germania 104
FI - Finlandia 100
GB - Regno Unito 79
IN - India 79
PL - Polonia 70
CA - Canada 62
NL - Olanda 62
RU - Federazione Russa 50
AR - Argentina 47
IQ - Iraq 44
JP - Giappone 39
ID - Indonesia 36
BJ - Benin 34
ES - Italia 33
IE - Irlanda 30
IR - Iran 30
JM - Giamaica 30
PK - Pakistan 30
AT - Austria 29
ZA - Sudafrica 29
TR - Turchia 28
UA - Ucraina 28
KR - Corea 27
CO - Colombia 25
ET - Etiopia 24
IL - Israele 24
JO - Giordania 24
PH - Filippine 24
SE - Svezia 24
EC - Ecuador 23
SA - Arabia Saudita 23
EG - Egitto 22
CL - Cile 21
CR - Costa Rica 21
DZ - Algeria 21
GR - Grecia 21
NZ - Nuova Zelanda 21
CH - Svizzera 20
GE - Georgia 20
GN - Guinea 20
MA - Marocco 20
AE - Emirati Arabi Uniti 19
LB - Libano 19
LU - Lussemburgo 19
NO - Norvegia 19
NP - Nepal 19
PS - Palestinian Territory 19
RO - Romania 19
UZ - Uzbekistan 19
AO - Angola 18
CZ - Repubblica Ceca 18
GT - Guatemala 18
KE - Kenya 18
MX - Messico 18
MY - Malesia 18
PT - Portogallo 18
BO - Bolivia 17
EE - Estonia 17
HN - Honduras 17
ME - Montenegro 17
PR - Porto Rico 17
PY - Paraguay 17
ZM - Zambia 17
AL - Albania 16
AZ - Azerbaigian 16
BA - Bosnia-Erzegovina 16
BE - Belgio 16
CV - Capo Verde 16
DK - Danimarca 16
MK - Macedonia 16
MR - Mauritania 16
RS - Serbia 16
SI - Slovenia 16
UY - Uruguay 16
YT - Mayotte 16
ZW - Zimbabwe 16
BB - Barbados 15
CI - Costa d'Avorio 15
LC - Santa Lucia 15
MD - Moldavia 15
ML - Mali 15
MW - Malawi 15
SN - Senegal 15
TW - Taiwan 15
XK - ???statistics.table.value.countryCode.XK??? 15
AF - Afghanistan, Repubblica islamica di 14
CU - Cuba 14
CY - Cipro 14
LV - Lettonia 14
SC - Seychelles 14
AD - Andorra 13
Totale 10.555
Salva come PNG Salva come JPEG
Città #
Ashburn 738
San Jose 562
Singapore 509
Fairfield 508
Seattle 231
Hong Kong 229
Woodbridge 213
Houston 180
Cambridge 177
Santa Clara 163
Council Bluffs 153
Wilmington 138
Ho Chi Minh City 137
Chandler 116
Los Angeles 114
Beijing 97
Hanoi 94
Ann Arbor 89
Boardman 88
Padova 87
Milan 72
Helsinki 69
New York 61
Lauterbourg 58
Chicago 55
San Diego 55
Medford 46
Princeton 45
Munich 42
Padua 42
Bytom 40
Buffalo 35
Cotonou 32
Hefei 32
São Paulo 31
Orem 30
Rome 30
Dallas 28
Des Moines 28
Tokyo 28
Dong Ket 25
Dublin 25
Nuremberg 21
Amman 20
Conakry 20
Warsaw 19
Addis Ababa 18
Haiphong 18
Kingston 18
Baghdad 17
Guangzhou 17
Lappeenranta 17
Phoenix 17
Baku 16
Denver 16
London 16
Lusaka 16
Seoul 16
Tbilisi 16
Vienna 16
Athens 15
Bamako 15
Castries 15
Jinan 15
Nairobi 15
Podgorica 15
Tashkent 15
Abidjan 14
Da Nang 14
Dakar 14
Frankfurt am Main 14
Havana 14
Luanda 14
Naples 14
Nouakchott 14
Rio de Janeiro 14
San José 14
Amsterdam 13
Bridgetown 13
Dushanbe 13
Montevideo 13
Panama City 13
Praia 13
Stockholm 13
Toronto 13
Andorra la Vella 12
Guatemala City 12
Harare 12
Lilongwe 12
Ljubljana 12
Redondo Beach 12
Salt Lake City 12
Shenyang 12
Vientiane 12
Auckland 11
Bến Tre 11
Libreville 11
Luxembourg 11
Managua 11
Miami 11
Totale 6.369
Salva come PNG Salva come JPEG
Nome #
Physical PEGylation to Prevent Insulin Fibrillation 305
PEG-polyaminoacid based micelles for controlled release of doxorubicin: Rational design, safety and efficacy study 275
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 255
Dexamethasone loaded liposomes by thin‐film hydration and microfluidic procedures: Formulation challenges 251
Polymer coated oncolytic adenovirus to selectively target hepatocellular carcinoma cells 247
Extracellular vesicles powered cancer immunotherapy: Targeted delivery of adenovirus-based cancer vaccine in humanized melanoma model 243
Thermosensitive "Smart" Surfaces for Biorecognition Based Cell Adhesion and Controlled Detachment 229
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 226
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 220
Cancer vaccines: an update on recent achievements and prospects for cancer therapy 215
Development of nanovehicles for co-delivery of colistin and ArnT inhibitors 213
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment 210
Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma 209
From Immunosuppression to Immunomodulation – Turning Cold Tumours into Hot 207
Unlocking the potential of microfluidic assisted formulation of exenatide-loaded solid lipid nanoparticles 207
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 203
Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model 199
PCSK9 promotes arterial medial calcification 196
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 192
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects 187
Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer 186
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 186
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model 185
661. Synergistic Anti-Tumor Efficacy of Immunogenic Adenovirus ONCOS-102 and Standard of Care Chemotherapy in Preclinical Mesothelioma Model 183
Screening of chemical linkers for development of pullulan bioconjugates for intravitreal ocular applications 181
408. Oncolytic Vaccines in Combination with PD-L1 Blockade for the Treatment of Melanoma 177
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 173
The evolution of adenoviral vectors through genetic and chemical surface modifications 172
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 170
Inhibition of SIRT1 deacetylase and p53 activation uncouples the anti-inflammatory and chemopreventive actions of NSAIDs 167
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies 165
The Anti-Proliferative Effect of L-Carnosine Correlates with a Decreased Expression of Hypoxia Inducible Factor 1 alpha in Human Colon Cancer Cells 165
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice. 165
Transplantation of autologous extracellular vesicles for cancer-specific targeting 163
Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review 160
220. Evaluation of the Efficacy of a New Oncolytic Vaccine Platform in Humanized Mice 157
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 156
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model 154
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity 151
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform 151
The Multifaceted Roles of Mast Cells in Immune Homeostasis, Infections and Cancers 151
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review 150
71. Boosting the Immunogenicity of an Oncolytic Vaccinia Virus By Expression of DAI Can Enhance Anti-Tumor Immunity in Humanized Mice 149
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2 149
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 148
Oncolytic Adenovirus-Based Immunotherapy for Malignant Mesothelioma: Preclinical Advances and Future Perspectives 146
Isoflavones in aglycone solution enhance ultraviolet B-induced DNA damage repair efficiency 141
622. Oncolytic Adenoviruses Loaded With Active Drugs as a Novel Drug Delivery System for Cancer Therapy 139
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs 138
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 136
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy 130
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines 130
L-Carnosine and Human Colon Cancer 125
MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy 119
Erratum: The anti-proliferative effect of L-carnosine correlates with a decreased expression of hypoxia inducible factor 1 alpha in human colon cancer cells (PLoS ONE (2014) 9, 5 (e96755) DOI: 10.1371/journal.pone.0096755) 119
Induction of an immune response by a nonreplicating adenoviruses-based formulation versus a commercial pseudo-SARS-CoV-2 vaccine 118
Application of array-CGH analysis in immune-virotherapy approach 116
Localized treatment of glioblastoma: a review of clinical strategies and advances in drug delivery systems 115
Dynamic 3D microfluidic platform for exploring combined targeted therapy, chemotherapy, and virotherapy delivery in ovarian cancer 109
In vitro immune evaluation of adenoviral vector-based platform for infectious diseases 109
I Vaccini 95
L-Carnosine inhibits KRAS-mediated HCT116 proliferation, by affecting ROS production and Hypoxia inducible factor (HIF-1) expression 88
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 82
Oncologia 81
Development of an in vitro method to assess the immunogenicity of biologics in the prevention of infectious diseases 75
A 3D coculture model of hepatocellular carcinoma: addressing challenges with glycopolymers re-targeted oncolytic viruses 74
Doxorubicin liposomes cell penetration enhancement and its potential drawbacks for the tumor targeting efficiency 70
null 66
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer 57
Redefining long-acting injectables: the emerging role of extracellular vesicles in sustained drug delivery 32
Breakable Organosilica Nanocapsules for the Intracellular Delivery of a Peptide With Promising Anti-Breast Cancer Activity 21
Structure-guided design of an LC3B-targeting PNA oligomer modulating autophagy and LC3B-mediated mRNA decay 14
Integrative strategies combining oncolytic adenovirus, anti-PD-1, and chemotherapy in a 3D TNBC model 13
Totale 11.261
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.002
article - articoli 31.769
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 968
Totale 65.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022537 0 0 0 60 59 27 27 134 80 13 22 115
2022/2023335 73 1 4 23 70 46 1 38 46 3 15 15
2023/2024254 10 44 38 19 9 10 18 17 8 6 46 29
2024/20251.152 9 44 41 51 130 55 71 90 89 49 194 329
2025/20266.142 322 461 926 1.003 464 237 724 450 614 370 293 278
2026/20271.134 319 246 278 291 0 0 0 0 0 0 0 0
Totale 11.261